Double maintains 1 strategies that include CRMD - CorMedix, Inc.
Current Value
$5.991 Year Return
Current Value
$5.991 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UNF | 41.56% | $3.16B | +6.68% | 0.81% |
DNLI | 31.60% | $2.00B | -29.07% | 0.00% |
DLR | 28.99% | $50.05B | +5.72% | 3.47% |
PRTA | 28.37% | $653.46M | -49.96% | 0.00% |
ELVN | 28.00% | $973.23M | +6.83% | 0.00% |
KYMR | 27.67% | $1.71B | -29.01% | 0.00% |
WING | 27.48% | $6.58B | -36.30% | 0.44% |
YMAB | 27.20% | $217.05M | -66.71% | 0.00% |
SNX | 27.07% | $9.01B | -9.71% | 1.67% |
ARCT | 26.85% | $276.62M | -68.85% | 0.00% |
KRYS | 26.67% | $5.21B | +1.76% | 0.00% |
NSIT | 26.10% | $4.69B | -20.24% | 0.00% |
FTRE | 26.10% | $677.40M | -80.55% | 0.00% |
PFGC | 25.96% | $12.64B | +9.91% | 0.00% |
IMNM | 25.35% | $583.44M | -68.94% | 0.00% |
AEIS | 25.24% | $3.64B | -2.74% | 0.48% |
AUR | 25.17% | $12.46B | +137.09% | 0.00% |
AMRX | 25.09% | $2.56B | +35.71% | 0.00% |
GPRO | 25.06% | $98.12M | -71.28% | 0.00% |
RGNX | 24.98% | $353.11M | -65.19% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
WEAT | -<0.01% | $115.75M | 0.28% |
DFSD | 0.02% | $4.39B | 0.16% |
EQLS | 0.06% | $4.80M | 1% |
GCOR | -0.06% | $352.35M | 0.08% |
MUNI | -0.11% | $1.83B | 0.35% |
NUAG | 0.11% | $56.52M | 0.21% |
PZA | 0.12% | $3.00B | 0.28% |
AVIG | -0.13% | $1.09B | 0.15% |
LQDW | -0.15% | $229.70M | 0.34% |
GTO | -0.15% | $1.90B | 0.35% |
IUSB | -0.16% | $33.05B | 0.06% |
DBO | -0.17% | $202.41M | 0.77% |
COMT | -0.21% | $684.20M | 0.48% |
FTGC | -0.21% | $2.52B | 1.02% |
OILK | -0.31% | $67.85M | 0.69% |
MUB | 0.34% | $39.67B | 0.05% |
JPST | 0.35% | $31.42B | 0.18% |
BNDW | 0.39% | $1.10B | 0.05% |
JUCY | -0.40% | $306.51M | 0.6% |
PDBC | 0.40% | $4.89B | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 31.22% | $4.76B | 0.35% |
XPH | 29.30% | $158.14M | 0.35% |
PTH | 28.81% | $107.91M | 0.6% |
IBB | 27.59% | $5.61B | 0.45% |
IWC | 26.38% | $797.08M | 0.6% |
EFAA | 26.08% | $100.03M | 0% |
QQQJ | 25.81% | $592.09M | 0.15% |
PINK | 25.45% | $138.92M | 0.5% |
CPRJ | 25.07% | $48.38M | 0.69% |
ARTY | 24.90% | $775.69M | 0.47% |
XHE | 24.64% | $174.19M | 0.35% |
IWO | 24.52% | $10.72B | 0.24% |
ARKG | 24.12% | $936.86M | 0.75% |
PBW | 23.95% | $213.72M | 0.65% |
VBK | 23.77% | $17.32B | 0.07% |
ISCG | 23.43% | $655.02M | 0.06% |
GNOM | 23.38% | $47.13M | 0.5% |
VTWO | 23.25% | $10.92B | 0.07% |
XT | 23.21% | $2.97B | 0.46% |
DRIV | 23.19% | $295.28M | 0.68% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BBDO | <0.01% | $10.83B | -15.18% | 3.50% |
CE | -0.01% | $6.32B | -66.96% | 4.45% |
LW | 0.02% | $7.72B | -46.45% | 2.51% |
WBX | 0.03% | $83.50M | -78.07% | 0.00% |
BDX | 0.05% | $65.01B | -7.05% | 1.80% |
GTN | -0.06% | $442.73M | -30.46% | 7.99% |
RTO | 0.09% | $11.63B | -23.29% | 2.54% |
ADEA | 0.10% | $1.46B | +25.51% | 1.63% |
UIS | -0.10% | $324.07M | -16.94% | 0.00% |
EMBC | 0.11% | $727.84M | -1.03% | 4.88% |
KMPR | -0.11% | $4.27B | +13.59% | 1.93% |
PAY | -0.13% | $3.44B | +29.28% | 0.00% |
LKQ | 0.13% | $11.22B | -16.85% | 2.88% |
AMT | 0.13% | $101.86B | +13.31% | 2.85% |
AXS | 0.15% | $8.17B | +54.61% | 1.78% |
RCEL | 0.15% | $194.02M | -48.41% | 0.00% |
TDS | 0.15% | $4.51B | +143.35% | 0.42% |
APOG | -0.16% | $1.05B | -18.82% | 2.24% |
TTD | -0.16% | $27.93B | -35.24% | 0.00% |
SYY | -0.16% | $36.84B | -5.82% | 2.69% |
Yahoo
BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that management will be participating in the 24th Annual Needham Virtual Healthcare Conference, taking place virtually on April 7-10, 2025. 24th Annual Needham Virtual Healthcare Conference Date:Tuesday, April 8, 2025Time:2:15p.m. EDTFormat:Fireside ChatWebc
SeekingAlpha
CorMedix's DefenCath cuts infection risk by 71% for dialysis patients. Despite its potential, CMD stock is fairly priced post-FDA approval. Read here for more.
Yahoo
Key Insights The considerable ownership by individual investors in CorMedix indicates that they collectively have a...
SeekingAlpha
CorMedix Inc.'s DefenCath reduces catheter infections by 71%, but the limited market potential challenges long-term adoption. Read more about CRMD stock here.
Yahoo
Cormedix Inc (CRMD) reports its first profitable quarter with strong revenue growth and strategic partnerships, despite challenges in price erosion and customer expansion.
Yahoo
‒ Q4 2024 Net Revenue of $31.2mm; 2024 Net Revenue of $43.5mm ‒ ‒ Q4 Net Income of $13.5mm and Adjusted EBITDA of $15.3mm ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ BERKELEY HEIGHTS, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced financial results for the fourth quarter and full year ended Decembe
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -18.06% | $195.31M | 0.85% |
TAIL | -17.11% | $87.65M | 0.59% |
BTAL | -16.83% | $416.76M | 1.43% |
TOTL | -13.40% | $3.51B | 0.55% |
CARY | -9.20% | $347.36M | 0.8% |
XONE | -9.17% | $631.21M | 0.03% |
SHYM | -8.77% | $318.40M | 0.35% |
IVOL | -8.52% | $476.36M | 1.02% |
IBTG | -7.92% | $1.82B | 0.07% |
FTSM | -7.86% | $6.38B | 0.45% |
UGA | -7.82% | $87.23M | 0.97% |
DFIP | -7.63% | $889.90M | 0.11% |
JMST | -7.34% | $3.54B | 0.18% |
GTIP | -7.32% | $144.36M | 0.12% |
TPMN | -6.93% | $33.32M | 0.65% |
CGCB | -6.86% | $2.01B | 0.27% |
TDTT | -6.81% | $2.38B | 0.18% |
FXY | -6.72% | $549.84M | 0.4% |
SHYD | -6.70% | $319.95M | 0.35% |
SPSK | -6.69% | $300.65M | 0.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GL | -18.45% | $11.08B | +20.01% | 0.75% |
MO | -15.44% | $96.57B | +35.61% | 6.83% |
POAI | -14.63% | $10.09M | -28.57% | 0.00% |
KDP | -12.77% | $47.68B | +13.32% | 2.55% |
OMCL | -11.32% | $1.66B | +28.62% | 0.00% |
GIS | -10.06% | $32.41B | -14.20% | 3.90% |
PRMB | -9.98% | $13.21B | +98.62% | 1.07% |
PEP | -9.45% | $204.52B | -12.12% | 3.52% |
WHF | -9.32% | - | - | 16.87% |
BPT | -9.14% | $12.33M | -81.88% | 0.00% |
NOC | -8.97% | $74.14B | +12.07% | 1.60% |
GRMN | -8.41% | $41.96B | +49.32% | 1.65% |
VRSK | -8.16% | $42.04B | +29.74% | 0.53% |
CPB | -8.07% | $11.75B | -8.27% | 3.73% |
GHI | -8.02% | $280.37M | -24.42% | 12.33% |
BRSP | -7.82% | $724.94M | -14.92% | 12.44% |
ABBV | -7.58% | $362.98B | +15.71% | 3.07% |
AGS | -7.25% | $500.47M | +38.15% | 0.00% |
EAT | -7.20% | $6.89B | +209.51% | 0.00% |
SJM | -7.09% | $12.61B | -0.90% | 3.59% |